N-Ethylhexedrone was patented by the German pharmaceutical corporation Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[1]The toxicity and lengthy-phrase health and fitness results of recreational N-ethylhexedrone use tend not to seem to have been resea